-
Cy7 NHS Ester: Practical Labeling and QC Guide
2026-09-10
Cy7 NHS ester is a water-soluble, sulfonated near-infrared reagent for labeling accessible amino groups on proteins and peptides. It is suited to aqueous biomolecule conjugation and near-infrared fluorescent imaging, but live-cell or in vivo use still requires assay-specific controls for labeling degree, free-dye removal, signal stability, and biological compatibility.
-
Amphotericin B: Applied Research Workflows
2026-09-09
Build reproducible fungal membrane, biofilm, and immune-signaling assays around Amphotericin B while controlling solubility and cytotoxicity variables. This guide also translates recent ergosterol-potentiation findings into practical combination screens and troubleshooting decisions.
-
Cytosolic DNA and TDP-43 Homeostasis
2026-09-09
A 2024 Journal of Biological Chemistry study identifies cytosolic DNA accumulation as a regulator of TDP-43 condensation, nuclear depletion, and production of a short TDP-43 isoform. Its experimental framework connects DNA uptake, DNA damage, nuclear-envelope stress, and ALS-linked TDP-43 mutation to a common homeostatic mechanism that can inform future DNA damage response and neurodegeneration studies.
-
Oleanolic acid: Reliable Cell Assay Workflows
2026-09-08
A scenario-based guide to using Oleanolic acid (SKU N1826) in viability, proliferation, and dual-loaded liposome studies. It connects formulation controls, stock preparation, analytical separation, and vendor-selection criteria to more interpretable laboratory data.
-
Dacomitinib (PF-00299804) in Ferroptosis Research
2026-09-08
Dacomitinib (PF-00299804) enables durable ErbB pathway suppression in signaling, resistance, apoptosis, and cell-cycle assays. This workflow-focused guide shows how to combine pan-HER target engagement with the mitochondrial ferroptosis framework reported for METTL17, while distinguishing established evidence from exploratory applications.
-
Ethacridine lactate monohydrate in Ectoderm Assays
2026-09-07
Use Ethacridine lactate monohydrate as a controlled microbial-inhibition variable in stem-cell, chromatin, and differentiation workflows—not as a substitute for aseptic technique. Its high reported solubility and ≥98% purity support practical stock preparation, while careful matrix controls help separate antiseptic effects from YAP-TEAD and super-enhancer biology.
-
O-GlcNAcylation Links Wnt Signaling to Bone Formation
2026-09-05
The reference study identifies O-GlcNAcylation as a critical metabolic relay linking Wnt3a stimulation to aerobic glycolysis, osteoblastogenesis, and bone repair. Its results place PDK1 Ser174 modification downstream of Wnt signaling and provide a framework for testing how anabolic signals alter glucose metabolism in bone-forming cells.
-
In Vitro Drug Response Metrics in Cancer Research
2026-09-05
Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a timing-aware framework for distinguishing proliferative arrest from cell killing, improving interpretation of drug-response experiments and translational model selection.
-
From Cargo to Cytosol: Making mRNA Delivery Visible
2026-09-04
A thought-leadership perspective on how ARCA Cy3 EGFP mRNA (5-moUTP) can help translational researchers separate cellular uptake, intracellular trafficking, endosomal escape, and productive EGFP reporter gene expression. The article connects direct fluorescence measurements with the delivery mechanisms highlighted in recent BEND lipid research.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody
2026-09-04
This product provides HRP-based detection of rabbit IgG primary antibodies in Western blotting, ELISA, IHC, and immunocytochemistry. It is intended for research workflows only, with assay-specific dilution and substrate conditions requiring local validation; it should not be used for diagnostic, medical, or non-rabbit primary-antibody applications without appropriate validation.
-
RITA (NSC 652287): Applied Research Workflows
2026-09-03
RITA (NSC 652287) combines MDM2–p53 pathway interrogation with DNA cross-link biology, making it useful for mechanism-focused cancer biology and renal carcinoma research. This guide shows how to separate growth inhibition from true cell killing, optimize dosing and apoptosis assay design, and interpret in vitro findings alongside tumor xenograft evidence.
-
Aconitase Assay in CD8+ T Cell Metabolism
2026-09-02
Learn how the Aconitase Activity Colorimetric Assay Kit can complement CD8+ T-cell immunometabolism studies without confusing aconitase activity with glycolytic or splicing endpoints. This guide connects iron-sulfur enzyme chemistry, oxidative damage measurement, and practical experimental design.
-
AZD6482: PI3Kβ Inhibitor Workflow
2026-09-02
AZD6482 enables isoform-resolved PI3Kβ studies across kinase signaling, adipocyte glucose uptake, and platelet biology. This workflow also explains how to use the compound cautiously in hypothesis-generating DM1 RNA-foci experiments without confusing an exploratory extension with evidence from the reference study.
-
Busulfan and the Limits of Ovarian Regeneration
2026-09-02
Busulfan is more than an ovarian injury reagent: it is a mechanistically defined DNA alkylating agent that can expose the difference between tissue damage, cellular depletion, and true lineage replacement. New dual-recombinase tracing strengthens the case that busulfan-injured mouse ovaries do not regenerate oocytes in vivo.
-
IWP-2 Workflow for Wnt Production Inhibition
2026-09-01
IWP-2 provides an upstream way to suppress Porcupine-dependent Wnt secretion, helping researchers connect pathway blockade with proliferation, invasion, apoptosis, and cell morphology. This practical guide combines product handling, a gastric cancer workflow, and high-content profiling principles inspired by a cardiomyopathy study.